Treating Schizophrenia with Muscarinic Antipsychotics | Steve Paul

FDA Approved Cobenfy: Non-Dopaminergic Treatment for Schizophrenia

7th Annual ALS ONE Research Symposium: Day 1 – Keynote Speaker: Dr. Eva Feldman, MD, PhD.

The Essential Role of Sleep in College Mental Health

Busting Myths about Psychosis & Antipsychotics with Dr Joanna Moncrieff

Treatment-Resistant Schizophrenia in Young Adulthood | The Dorm & Silver Hill Hospital

Martin's Experience Managing Schizophrenia Without Medication

Change Makers: Bill Meury on Transformative Medicines

NeuRA Talks - Freedom from schizophrenia by Professor Cyndi Shannon Weickert

How To Speak Fluently In English About Almost Anything

Announcement of the 2024 Holberg Prize and Nils Klim Prize

Practical Strategies to Address the Impact of Increased Sodium Intake on CVD Risk

Activating Neurons in the Skin to Relieve Symptoms of Chronic Stress

Current Treatment Practices for Schizophrenia Spectrum Disorders

Let's Talk About Bipolar Disorder (What Happens When You Go Off Medication)

What is a trace amine-associated receptor 1 agonist? Can we treat schizophrenia with it?

The causes of psychosis with Dr. Kwame McKenzie

Novel and Emerging Treatments for Schizophrenia Presented by Dr. Christoph Corral

Healthy Minds - 409 - Schizophrenia: Potential Breakthroughs, Treatment, and Prevention

Why would an acetylcholine agonist make psychosis better?

First Clinical Trial of Ketogenic Diet for Bipolar & Schizophrenia - Shebani Sethi, MD